Investor Relations


Stock Quote (NASDAQ: PODD)

Price:
45.33
Change:
+ 0.07
Day High:
45.69
Day Low:
44.85
Volume:
386,800
2:33 PM ET on Nov 24, 2014
Delayed ~20 min. By eSignal.
Stock price graph
     

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Nov 5, 2014
Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources

Nov 5, 2014
Insulet Reports Third Quarter 2014 Results

View all »Events & Presentations

Nov 20, 2014
Insulet Corporation to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
Webcast Listen to webcast

Nov 11, 2014
Insulet Corporation to Present at the Stephens Fall Investment Conference
Webcast Listen to webcast